Israel Englander Arcturus Therapeutics Holdings Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Millennium Management LLC holds 236,073 shares of ARCT stock, worth $3.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

236,073

Previous 555,024 57.47%

Holding current value

$3.99 Million

Previous $13.5 Million 59.46%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $5.77 Million - $8.09 Million	-318,951 Reduced 57.47%	236,073 $5.48 Million
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $9.65 Million - $17.6 Million	396,505 Added 250.13%	555,024 $13.5 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $776,346 - $1.07 Million	24,859 Added 18.6%	158,519 $5.35 Million
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $2.16 Million - $4.02 Million	121,896 Added 1036.18%	133,660 $4.21 Million
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $2.19 Million - $2.97 Million	-91,647 Reduced 88.62%	11,764 $337,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $912,993 - $1.49 Million	62,024 Added 149.86%	103,411 $2.48 Million
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $324,173 - $528,673	22,926 Added 124.19%	41,387 $702,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $2.43 Million - $4.12 Million	-186,135 Reduced 90.98%	18,461 $274,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $2.51 Million - $6.38 Million	204,596 New	204,596 $3.22 Million
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $3.05 Million - $4.24 Million	-89,075 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $2.48 Million - $5.19 Million	89,075 New	89,075 $4.26 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $2.71 Million - $4.43 Million	-105,138 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $2.88 Million - $6.46 Million	74,273 Added 240.64%	105,138 $4.34 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $1.07 Million - $3.82 Million	30,865 New	30,865 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $235,287 - $396,580	-6,276 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.66 - $58.27 $1.19 Million - $5.48 Million	-94,000 Reduced 93.74%	6,276 $293,000
Q1 2020 May 14, 2020	BUY	$9.31 - $18.26 $933,569 - $1.83 Million	100,276 New	100,276 $1.36 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $449M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account